国家神经系统疾病临床医学研究中心数据管理与共享系统

Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

Peripheral blood test provides a practical method for glioma evaluation and prognosis prediction

第一作者:Wang Zhi-Liang

通讯作者:Wang Zheng,Jiang Tao

NLR; glioma; molecular markers; prognosis

基本信息

  • 负责人:Wang Zhi-Liang
  • 数据来源: OTHERS
  • 论文编号:OTHERS20190817
  • 发表时间:2019-03-26

2019-03-26

已发表文章

发表杂志:CNS Neurosci Ther

发表类型: Original Article

影响因子(IF): 5.243

PMID: 30912613 Pubmed原文链接 全文下载

主要研究背景及目的

方法

We included 260 WHO grades II-IV patients who had preoperative peripheral blood test result from Sanbo hospital as training set. The 66 patients from Tiantan hospital was obtained for validation. RNA sequencing data from CGGA and TCGA datasets were used to evaluate the features of neutrophil subtype and lymphocyte subtype in glioma.

结论

Our data demonstrated that NLR was an important prognostic factor in glioma. We classified that the immune subtype of glioma may contribute to a better understanding of disease pathogenesis and lead to the identification of new therapeutic targets for glioma patients.

主要结果

We revealed that the count of preoperative lymphocytes, eosinophils and neutrophils were associated with glioma grades. Neutrophil-to-lymphocyte ratio (NLR) <3.2 was associated with better prognosis, whereas increased NLR was strongly corresponding with a poor prognosis. Lymphocyte type glioma patients demonstrated a positive correlation with isocitrate dehydrogenase (IDH) mutation and lower grade. IDH mutant glioma contained a higher proportion of tumor-infiltrating lymphocytes than IDH wild-type glioma. The immune subtype (neutrophil subtype and lymphocyte subtype) was an independent prognostic factor in glioma.